Published • loading... • Updated
Alzheimer's blood test could 'revolutionise' diagnosis
The trial involving 1,100 UK patients evaluates a £100 blood test measuring p-tau217 to improve early Alzheimer's diagnosis and support timely treatment access within the NHS.
- A national trial by University College London is recruiting 1,100 people from 20 NHS memory clinics to test a new blood test for early signs of Alzheimer's disease.
- The trial is part of the £10 million Blood Biomarker Challenge project, supported by the People's Postcode Lottery, aiming for routine dementia screening.
- Professor Jonathan Schott is leading the ADAPT trial, which aims to improve Alzheimer's diagnosis accuracy from 70% to 90% by combining a blood test with clinical assessments.
- Professor Fiona Carragher highlighted that late dementia diagnoses often limit access to support and treatment.
Insights by Ground AI
Podcasts & Opinions
41 Articles
41 Articles
UK launches breakthrough Alzheimer's blood test trial for NHS use
A groundbreaking UK clinical trial led by UCL aims to revolutionise Alzheimer’s diagnosis using a simple blood test The ADAPT (Alzheimer’s Disease Diagnosis and Plasma pTau217) team, led by Professor Jonathan Schott and Dr. Ashvini Keshavan, is investigating whether a blood test that measures the protein p-tau217 can enhance the early and accurate diagnosis of Alzheimer’s disease. The landmark trial is part of the Blood Biomarker Challenge, an i…
A clinical trial in the UK will be launched to evaluate the effectiveness of blood tests to improve and accelerate the diagnosis of Alzheimer's disease.
·France
Read Full Article
Coverage Details
Total News Sources41
Leaning Left7Leaning Right7Center17Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
L 23%
C 55%
R 22%
Factuality
To view factuality data please Upgrade to Premium
